Dose‐dependent testosterone sensitivity of the steroidal passport and GC‐C‐IRMS analysis in relation to the UGT2B17 deletion polymorphism
- 22 July 2015
- journal article
- research article
- Published by Wiley in Drug Testing and Analysis
- Vol. 7 (11-12) , 1063-1070
Abstract
The newly implemented Steroid Module of the Athlete Biological Passport has improved doping tests for steroids. A biomarker included in this passport is the urinary testosterone glucuronide to epitestosterone glucuronide (T/E) ratio, a ratio greatly affected by a deletion polymorphism in UGT2B17. Suspect urine doping tests are further analyzed with gas chromatography‐combustion‐isotope ratio mass spectrometry (GC‐C‐IRMS) to determine the origin of the androgen. In this study, we investigated the sensitivity of the steroidal module and the IRMS analysis, in subjects administered with three doses of testosterone enanthate (500, 250, and 125 mg), in relation to the UGT2B17 polymorphism. All subjects carrying the UGT2B17 enzyme reached the traditionally used threshold, a T/E ratio of 4, after all three administered doses, whereas none of the subjects devoid of this enzyme reached a T/E of 4. On the other hand, using the athlete biological passport and IRMS analysis, all three doses could be detected to a high degree of sensitivity. The concentrations of all steroids included in the steroidal module were dose dependently increased, except for epitestosterone which decreased independent of dose. The decrease in epitestosterone was significantly associated with circulatory levels of testosterone post dose (rs=0.60 and p=0.007). In conclusion, these results demonstrate that administration of a single dose of 125–500 mg testosterone enanthate could be detected using the athlete biological passport, together with IRMS. Since IRMS is sensitive to testosterone doping independent of UGT2B17 genotype, also very small changes in the steroidal passport should be investigated with IRMS. Copyright © 2015 John Wiley & Sons, Ltd.Keywords
Funding Information
- World Anti-Doping Agency (WADA)
This publication has 26 references indexed in Scilit:
- Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroidsThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5′-diphospho-glucuronosyltransferase (UGT2B17) gene.Pharmacogenetics and Genomics, 2011
- Stable isotope ratio profiling of testosterone preparationsDrug Testing and Analysis, 2010
- Detection of testosterone administration based on the carbon isotope ratio profiling of endogenous steroids: international reference populations of professional soccer playersBritish Journal of Sports Medicine, 2009
- Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping testsSteroids, 2009
- Doping Test Results Dependent on Genotype of Uridine Diphospho-Glucuronosyl Transferase 2B17, the Major Enzyme for Testosterone GlucuronidationThe Journal of Clinical Endocrinology & Metabolism, 2008
- Determination of 13 C/ 12 C ratios of endogenous urinary steroids: method validation, reference population and application to doping control purposesRapid Communications in Mass Spectrometry, 2008
- A diurnal variation in testicular hormone production is maintained following gonadotrophin suppression in normal menClinical Endocrinology, 2006
- Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15Genomics, 2004
- The mechanism of the synthesis of 16-androstenes in human testicular homogenatesThe Journal of Steroid Biochemistry and Molecular Biology, 1989